Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$1.46 - $3.55 $36,792 - $89,460
-25,200 Closed
0 $0
Q1 2022

May 13, 2022

SELL
$2.66 - $6.63 $27,664 - $68,952
-10,400 Reduced 29.21%
25,200 $85,000
Q4 2021

Feb 11, 2022

SELL
$6.07 - $12.0 $222,162 - $439,200
-36,600 Reduced 50.69%
35,600 $216,000
Q3 2021

Nov 12, 2021

BUY
$6.79 - $13.9 $173,599 - $355,381
25,567 Added 54.83%
72,200 $508,000
Q2 2021

Aug 12, 2021

BUY
$9.43 - $16.6 $188,911 - $332,547
20,033 Added 75.31%
46,633 $641,000
Q1 2021

May 17, 2021

BUY
$9.71 - $18.6 $258,286 - $494,760
26,600 New
26,600 $285,000
Q1 2020

May 06, 2020

SELL
$3.21 - $7.06 $61,953 - $136,258
-19,300 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$6.52 - $9.42 $2,608 - $3,768
400 Added 2.12%
19,300 $173,000
Q1 2019

May 13, 2019

BUY
$7.5 - $15.31 $141,750 - $289,359
18,900 New
18,900 $151,000

About Evelo Biosciences, Inc.


  • Ticker EVLO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,994,000
  • Description
  • Evelo Biosciences, Inc., a biotechnology company, discovers and develops oral biologics for the treatment of inflammatory diseases and cancer. It is developing EDP1815, a whole-microbe candidate for the treatment of inflammatory diseases; and is in Phase 2 clinical trial for the treatment of psoriasis and atopic dermatitis, as well as for the hy...
More about EVLO
Track This Portfolio

Track State Of Wisconsin Investment Board Portfolio

Follow State Of Wisconsin Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wisconsin Investment Board with notifications on news.